IL266385A - Intelligent transfer of molecules for ingestion and digestion - Google Patents

Intelligent transfer of molecules for ingestion and digestion

Info

Publication number
IL266385A
IL266385A IL266385A IL26638519A IL266385A IL 266385 A IL266385 A IL 266385A IL 266385 A IL266385 A IL 266385A IL 26638519 A IL26638519 A IL 26638519A IL 266385 A IL266385 A IL 266385A
Authority
IL
Israel
Prior art keywords
ingested
intelligent delivery
absorbed molecules
absorbed
molecules
Prior art date
Application number
IL266385A
Other languages
English (en)
Hebrew (he)
Inventor
M Petyaev Ivan
orlowski Marek
Original Assignee
Immd Sp Zo O
M Petyaev Ivan
orlowski Marek
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PL419363A external-priority patent/PL419363A1/pl
Priority claimed from GBGB1705491.7A external-priority patent/GB201705491D0/en
Application filed by Immd Sp Zo O, M Petyaev Ivan, orlowski Marek filed Critical Immd Sp Zo O
Publication of IL266385A publication Critical patent/IL266385A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G1/00—Cocoa; Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/30—Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/32—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds
    • A23G1/36—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds characterised by the fats used
    • A23G1/38—Cocoa butter substitutes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/065—Diphenyl-substituted acyclic alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G2200/00—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF containing organic compounds, e.g. synthetic flavouring agents
    • A23G2200/08—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF containing organic compounds, e.g. synthetic flavouring agents containing cocoa fat if specifically mentioned or containing products of cocoa fat or containing other fats, e.g. fatty acid, fatty alcohol, their esters, lecithin, paraffins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Polymers & Plastics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
IL266385A 2016-11-04 2019-05-01 Intelligent transfer of molecules for ingestion and digestion IL266385A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
PL419363A PL419363A1 (pl) 2016-11-04 2016-11-04 Inteligentne dostarczanie przyjmowanych i wchłanianych cząsteczek
GB201618733 2016-11-07
GBGB1705491.7A GB201705491D0 (en) 2017-04-05 2017-04-05 Intelligent delivery of ingested and absorbed molecules
PCT/EP2017/078242 WO2018083271A1 (en) 2016-11-04 2017-11-03 Inteligent delivery of ingested and absorbed molecules

Publications (1)

Publication Number Publication Date
IL266385A true IL266385A (en) 2019-06-30

Family

ID=60382179

Family Applications (1)

Application Number Title Priority Date Filing Date
IL266385A IL266385A (en) 2016-11-04 2019-05-01 Intelligent transfer of molecules for ingestion and digestion

Country Status (8)

Country Link
US (2) US11696920B2 (enExample)
EP (1) EP3534884A1 (enExample)
JP (1) JP2019534329A (enExample)
CN (1) CN110198706A (enExample)
BR (1) BR112019008739A2 (enExample)
CA (1) CA3042592A1 (enExample)
IL (1) IL266385A (enExample)
WO (1) WO2018083271A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12094109B2 (en) * 2018-10-19 2024-09-17 Takeda Pharmaceutical Company Limited Image scoring for intestinal pathology
MX2022001238A (es) * 2019-08-13 2022-07-13 Team Foods Colombia Sa Composicion lipidica que comprende antioxidantes y polifenoles naturales como alternativa no farmacologica para el tratamiento y la prevencion de nafld.
CN115305207B (zh) * 2022-07-01 2024-04-12 厦门大学 一种全合成培养基、制备方法及其用于三孢布拉氏霉菌的培养方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05292885A (ja) 1992-04-22 1993-11-09 Asahi Denka Kogyo Kk チョコレート組成物
DK1997498T3 (da) * 2001-06-18 2012-07-30 Neptune Technologies & Bioressources Inc Krillekstrakter til forebyggelse og/eller behandling af kardiovaskulære sygdomme
MY135783A (en) * 2001-09-07 2008-06-30 Meiji Dairies Corp Nutritional composition for controlling blood sugar level
US20040219188A1 (en) * 2003-05-02 2004-11-04 Comer Gail M. Composition and methods for nutritional management of patients with hepatic disease
AU2003275419A1 (en) * 2003-10-03 2005-05-19 Green Meadows Research, Llc A And L Goodbody Lotus and methyl donors
WO2006063219A2 (en) * 2004-12-09 2006-06-15 Pro-Health, Inc. Product and method for oral administration of nutraceuticals
ES2241503B2 (es) * 2005-04-19 2008-07-01 Eduardo Sabio Rey Procedimiento para preparar formulaciones enriquecidas en licopeno libres de disolventes organicos, formulaciones obtenidas, composiciones que comprenden dichas formulaciones y uso de las mismas.
AU2011218634B2 (en) 2005-10-26 2013-06-20 Abbott Laboratories Infant formulas containing docosahexaenoic acid and lutein
JP2010538674A (ja) * 2007-09-19 2010-12-16 オフサルモファーマ・アクチェンゲゼルシャフト 栄養補助剤およびそのような補助剤を含む強化食品
JP5950292B2 (ja) 2008-12-05 2016-07-13 味の素株式会社 栄養組成物
US20100159029A1 (en) 2008-12-23 2010-06-24 Alcon Research, Ltd. Composition and nutritional supplements for improving ocular health and reducing ocular inflammatory response
IT1393710B1 (it) * 2009-04-29 2012-05-08 Graal Srl Composizioni orobuccali contenenti una miscela di luteina e zeaxantina.
EP2542096B1 (en) * 2010-03-05 2015-07-15 Ophthalmopharma AG Nutraceutical chocolate or compound chocolate product
US20140205627A1 (en) * 2010-04-30 2014-07-24 U.S. Nutraceuticals, Llc D/B/A Valensa International Composition and method to improve blood lipid profiles and reduce low density lipoprotein (ldl) per-oxidation in humans using algae based oils and astaxanthin
CN101816330B (zh) * 2010-05-31 2012-04-18 澳优乳业（中国）有限公司 一种含β-胡萝卜素的婴幼儿奶粉及其制备方法
GB201101669D0 (en) 2011-01-31 2011-03-16 Ip Science Ltd Carotenoid particles and uses thereof
US20120252888A1 (en) 2011-03-29 2012-10-04 Palupa Medical Ltd. Compositions and Methods for Treating Neurologic Disorders
GB201120772D0 (en) 2011-12-02 2012-01-11 Ip Science Ltd Cocoa-based food products
US20140170247A1 (en) * 2012-09-14 2014-06-19 Guardion Health Sciences, Llc Emulsion of Carotenoids and Ocular Antioxidants
FR2996136B1 (fr) * 2012-09-28 2015-01-02 Inneov Lab Utilisation d'une association d'au moins un acide gras polyinsature et d'au moins un carotenoide pour ameliorer la qualite des ongles.
US9629820B2 (en) * 2012-12-24 2017-04-25 Qualitas Health, Ltd. Eicosapentaenoic acid (EPA) formulations
WO2015073515A1 (en) 2013-11-12 2015-05-21 Abbott Laboratories Uses of nutritional compositions including natural vitamin e, and polyunsaturated fatty acid

Also Published As

Publication number Publication date
EP3534884A1 (en) 2019-09-11
BR112019008739A2 (pt) 2019-07-09
US20230310470A1 (en) 2023-10-05
US20200261482A1 (en) 2020-08-20
CN110198706A (zh) 2019-09-03
CA3042592A1 (en) 2018-05-11
JP2019534329A (ja) 2019-11-28
US11696920B2 (en) 2023-07-11
WO2018083271A1 (en) 2018-05-11

Similar Documents

Publication Publication Date Title
HUS2500022I1 (hu) Terápiás ellenanyagok és alkalmazásaik
IL290571A (en) Molecules that bind pd-1 and methods of using them
ZA201907815B (en) Subcutaneous formulations of anti-cd38 antibodies and their uses
IL256179A (en) lag-3 binding molecules and methods of using them
GB201519858D0 (en) Therapeutic combinations comprising anti-CD73 antibodies and uses thereof
IL251512A0 (en) Mist sprayer and its uses
SG11201708624YA (en) Therapeutic antibodies and uses thereof
IL266385A (en) Intelligent transfer of molecules for ingestion and digestion
PL3331853T3 (pl) Wybrany amid kwasu γ-hydroksymasłowego i jego zastosowania w leczeniu niewłaściwego użycia alkoholu
GB201705491D0 (en) Intelligent delivery of ingested and absorbed molecules